Sven Arne Andréasson
Directeur/Bestuurslid bij MENDUS AB
Vermogen: - $ op 31-05-2024
Actieve functies van Sven Arne Andréasson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MENDUS AB | Directeur/Bestuurslid | 01-01-2020 | - |
Independent Dir/Board Member | 01-01-2020 | - | |
Stefan Forsberg Consulting AB | Corporate Officer/Principal | - | - |
Galenos SRL | Directeur/Bestuurslid | 01-01-2014 | - |
Corporate Officer/Principal | 01-01-2014 | - | |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Directeur/Bestuurslid | - | - |
Operations Leadership Oil AB | Voorzitter | 15-10-2010 | - |
Loopbaan van Sven Arne Andréasson
Eerdere bekende functies van Sven Arne Andréasson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Directeur/Bestuurslid | 01-01-2009 | 23-06-2023 |
Independent Dir/Board Member | 01-01-2009 | 23-06-2023 | |
NOVAVAX, INC. | Corporate Officer/Principal | 02-06-2014 | 01-05-2023 |
MENDUS AB | Directeur/Bestuurslid | 01-01-2013 | 26-05-2016 |
Independent Dir/Board Member | 01-01-2013 | 26-05-2016 | |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Algemeen Directeur | 01-03-2012 | 01-11-2013 |
░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░ | ░░░░░░░░░ | - | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░ ░░░░░░░░░ | ░░░░░░░░░ | - | - |
░░░░░ ░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ | - | - |
░░░░░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░ | - | - |
░░░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Sven Arne Andréasson
Stockholm School of Economics | Undergraduate Degree |
Statistieken
Internationaal
Zweden | 14 |
België | 5 |
Frankrijk | 4 |
Operationeel
Director/Board Member | 9 |
President | 6 |
Corporate Officer/Principal | 4 |
Sectoraal
Health Technology | 14 |
Commercial Services | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
ACTIVE BIOTECH AB | Health Technology |
CANTARGIA AB | Health Technology |
NOVAVAX, INC. | Health Technology |
MENDUS AB | Health Technology |
Bedrijven in privébezit | 19 |
---|---|
TiGenix NV
TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
Beta-Cell NV
Beta-Cell NV Miscellaneous Commercial ServicesCommercial Services Beta-Cell NV is a Belgian company that offers a cell replacement therapy for diabetes. The private company is based in Brussels, Belgium. The company's therapy provides a cure for diabetes, which affects people of all ages, genders, and ethnicities. | Commercial Services |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Health Technology |
Operations Leadership Oil AB | |
Pharmacia AB | Health Technology |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Commercial Services |
Novavax AB
Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Health Technology |
ERYTech Pharma SA
ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France. | Health Technology |
Sista versen 26366 AB
Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Sista Versen 26366 AB discovers treatments for inflammatory disorders. Their treatment is based on properties of new classes of endogenous host defense peptides from proteins within the coagulation cascade, which display potent immune-modulating properties. The firm develops drugs that prevent sepsis development. The company was founded by Artur Schmidtchen and Nils Martin Malmsten on October 26, 2009 and is headquartered in Lund, Sweden. | Health Technology |
Cellastra, Inc.
Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Health Technology |
Galenos SRL | |
Kabivitrum AB | |
Stefan Forsberg Consulting AB | |
Advet AB | |
Advet Production AB | |
Pharmacia SAS | |
Kabi Pharmacia | |
Pharmacia Arzneimittel GmbH
Pharmacia Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Pharmacia Arzneimittel GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ratingen, Germany. | Health Technology |
Kabipharmacia International
Kabipharmacia International Pharmaceuticals: MajorHealth Technology Kabipharmacia International is a French company that manufactures pharmaceutical products. | Health Technology |